[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Indias Indoco Remedies manufacturing facility for ster...[ Price : $8.95]
Data from an AstraZeneca interim analysis of its SERENA-6 Phase 3 breast cancer trial show that camizestrant in combination with a...[ Price : $8.95]
FDA clears a Google 510(k) for its Loss of Pulse Detection feature and its use on the Pixel Watch 3.[ Price : $8.95]
CDERs 10th yearly drug safety report highlights the FY 2024 establishment of two new units contributing to drug safety.[ Price : $8.95]
Canadian researchers find that 16% of patients in Phase 2 oncology trials receive treatments that are later approved by FDA for th...[ Price : $8.95]
FDA clears an Abanza 510(k) for its WasherCap Mini fixation system for soft tissue repair, including meniscal root repair and ante...[ Price : $8.95]
FDA accepts for review a Regeneron Pharmaceuticals BLA resubmission for odronextamab in relapsed/refractory follicular lymphoma.[ Price : $8.95]
GenBioPro, which manufactures FDA-approved generic mifepristone, says it wants to be added to the list of defendants in a suit see...